Additional Details
-
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Brigham and Womens HospitalBoston MA. 02115View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
New York UniversityNew York NY. 10016View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
University of MiamiMiami FL. 33136View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
University of WashingtonSeattle WA. 98109View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Duke University Medical CenterDurham NC. 27710View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
University of California at San FranciscoSan Francisco CA. 94143View Details -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
University of MichiganAnn Arbor MI. 48109View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Temple University Hospital - Main CampusPhiladelphia PA. 19140View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of MinnesotaMinneapolis MN. 55455View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Thomas Jefferson UniversityPhiladelphia PA. 19107View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
MUSCCharleston SC. 29425View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Discovery Clinical TrialsSan Antonio TX. 78229View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Icahn School of Medicine at Mount SinaiNew York NY. 10029View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Baylor University Medical CenterDallas TX. 75246View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of ColoradoDenver CO. 80204View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Crown ResearchTampa FL. 33614View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of Wisconsin-MadisonMadison WI. 53792View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of FloridaGainesville FL. 32610View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Eunix Clinical ResearchOrlando FL. 32807View Details -
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
CTR South CaryCary NC. 27518View Details